| BCBS Oklahoma Medical Policies | Hematopoietic Cell Transplantation for Genetic Diseases and | 2026-06-15 |
| BCBS Oklahoma Medical Policies | Hematopoietic Cell Transplantation for Primary Systemic | 2026-06-15 |
| BCBS Oklahoma Medical Policies | Hematopoietic Cell Transplantation for Solid Tumors of | 2026-06-15 |
| BCBS Oklahoma Medical Policies | Hematopoietic Cell Transplantation in the Treatment of Germ | 2026-06-15 |
| BCBS Oklahoma Medical Policies | Insulin Potentiation Therapy | 2026-06-15 |
| BCBS Oklahoma Medical Policies | Lecanemab-irmb | 2026-06-15 |
| BCBS Oklahoma Medical Policies | Mepolizumab | 2026-06-15 |
| BCBS Oklahoma Medical Policies | Myoelectric Prosthetic and Orthotic Components for the | 2026-06-15 |
| BCBS Oklahoma Medical Policies | Secukinumab | 2026-06-15 |
| BCBS Oklahoma Medical Policies | Stationary Ultrasonic Diathermy Devices | 2026-06-15 |